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We have shown that the binding of simian immunodeficiency virus (SIV) to Jurkat T cells expressing CD4 receptor strongly
induces mitogen-activated protein (MAP) kinase kinase (MEK) and extracellular signal-regulated kinases 1 and 2 (ERK1/2)
and only weakly induces p38 MAP kinase and c-Jun N-terminal kinase (JNK). Similarly, T-tropic NL4–3 virus, which uses both
CD4 and CXCR4 receptors for entry, stimulated in these cells the MEK/ERK MAP kinase (MAPK) pathway in a CD4
receptor-dependent manner (Popik and Pitha, 1998). In contrast, both macrophage-tropic SIVmac316 and T cell-tropic
SIVmac239, which in addition to CD4 require CCR5 coreceptor for entry, significantly enhanced early MEK/ERK, p38 MAPK,
and JNK signaling in Jurkat cells expressing constitutively or transiently the CCR5 receptor. Together, this study provides the
evidence that viruses using CXCR4 or CCR5 receptors for entry may differentially use signaling properties of their specific
coreceptors to stimulate MAP kinase cascades. In addition, although SIVmac239 and SIVmac316 use different structural
domains of the CCR5 receptor for entry, both viruses stimulate early phosphorylation of MEK, ERK, p38, and JNK indepen-
dently of their tropism and replication. © 1998 Academic Press
INTRODUCTION
An interaction between the viral envelope glycoprotein
and cellular CD4 receptor is generally required but not
sufficient for cellular entry of human immunodeficiency
virus (HIV) or simian immunodeficiency virus (SIV). Addi-
tional coreceptors that serve as entry cofactors have
been recently identified as seven-transmembrane G pro-
tein-coupled chemokine receptors (Alkhatib et al., 1996;
Choe et al., 1996; Deng et al., 1996; Doranz et al., 1996;
Dragic et al., 1996; Feng et al., 1996). Most T cell-adapted
and primary HIV-1 strains use CXCR4 for entry (Berson et
al., 1996; Feng et al., 1996), whereas macrophage-tropic
viruses mostly use CCR5 receptor (Alkhatib et al., 1996;
Choe et al., 1996; Deng et al., 1996; Dragic et al., 1996). In
addition to dual-tropic viruses that use CXCR4 or CCR5
for entry, some viruses are able to use also CCR3 or
CCR2b receptors (Choe et al., 1996; Doranz et al., 1996).
The newly identified BOB/GPR15 (Deng et al., 1997; Far-
zan et al., 1997a; Heiber et al., 1996) and BONZO/STRL33
(Alkhatib et al., 1997; Liao et al., 1997) may serve as
coreceptors for SIVmac, HIV-2, and certain strains of
HIV-1. Viral envelope glycoproteins interact rather poorly
with chemokine receptors; however, this interaction is
significantly enhanced after binding to CD4 (Trkola et al.,
1996; Werner et al., 1990; Wu et al., 1996). Formation of
the viral envelope–CD4–CXCR4 complex has been re-
cently shown for T-tropic HIV-1 (Lapham et al., 1996), and
a direct, CD4-dependent interaction of viral envelope
glycoproteins with CCR5 coreceptor has been demon-
strated for selected CCR5-tropic HIV-1, HIV-2, and SIV
(Hill et al., 1997).
The expression of CD4 receptor is not always required
for viral entry, and it has been shown that some labora-
tory-adapted HIV-2 and feline immunodeficiency virus
(FIV) strains can productively infect CD4-negative cells in
a CXCR4-dependent manner (Endres et al., 1996; Reeves
et al., 1997; Willett et al., 1997). Similarly, CCR5 receptor
was shown to support infection of different SIV strains
independently of the presence of CD4 receptor (Edinger
et al., 1997a).
Despite that chemokine receptor signaling is not re-
quired for viral entry (Atchison et al., 1996; Farzan et al.,
1997b; Gosling et al., 1997), signaling events were sug-
gested to play a role in postentry events (Chackerian et
al., 1997). It has been shown that the interaction of the
HIV-1 envelope glycoproteins from T-tropic and macro-
phage-tropic viruses rapidly induces phosphorylation of
the tyrosine kinase Pyk2 (Davis et al., 1997) and macro-
phage-tropic HIV and SIV induce calcium signaling
through the CCR5 receptor (Weissman et al., 1997). Al-
though binding of stromal cell-derived factor-1 (SDF-1) to
CXCR4 stimulates mitogen-activated protein (MAP) ki-
nase kinase (MEK)/extracellular signal-regulated kinase
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(ERK) pathway, interaction of the viral envelope with
CXCR4 did not signal through this pathway (Popik and
Pitha, 1998). However, the MEK/ERK pathway could be
activated by binding of T-tropic HIV-1 envelope to CD4
receptor (Briant et al., 1998; Popik and Pitha, 1998).
Unlike HIV-1, both T-tropic and macrophage-tropic SIV
use efficiently CCR5 receptor for entry but are unable to
use CXCR4 receptor (Edinger et al., 1997b; Kirchhoff et
al., 1997; Marcon et al., 1997). In contrast to CCR5 recep-
tor ligands that require the second extracellular loop of
the receptor for binding and signaling, interaction with
macrophage-tropic HIV-1 involves several regions of the
CCR5 receptor (Alkhatib et al., 1997; Edinger et al., 1997b;
Samson et al., 1997; Wu et al., 1997). These observations
raise the possibility that chemokine receptor signaling
induced by chemokine binding may differ from that in-
duced in the process of viral entry. In addition, different
structural requirements for CCR5 receptor in the process
of entry of macrophage and T cell-tropic SIVmac (Edinger
et al., 1997b) suggested different signaling outcome in
cells infected with these viruses. To test this presump-
tion, we have therefore investigated whether binding of
T-tropic SIVmac239 and its close derivative, macro-
phage-tropic SIVmac316 (Mori et al., 1992), is able to
signal through the CCR5 receptor and activate MEK/ERK
MAP kinase (MAPK) pathways. We have found that bind-
ing of both SIV strains to CD4-positive and CCR5-nega-
tive Jurkat T cells resulted in activation of the MEK and
ERK1/2 and only limited stimulation of p38 and c-Jun
N-terminal kinase (JNK). However, binding of SIV to Jur-
kat cells expressing constitutively or transiently CCR5
receptor resulted not only in an enhancement of MEK
and ERK1/2 phosphorylation but also significantly in-
creased activity of p38 and JNK. In contrast, T-tropic
HIV-1 NL4–3 did not appreciably activate MAP kinase
pathways through its interaction with the CXCR4 recep-
tor. Together, our results suggest that interaction of the
HIV-1 and SIVmac viruses with their specific chemokine
receptors in the process of entry differentially activates
MAP kinase pathways in infected cells. In addition, we
show that despite using different domains of the CCR5
receptor for entry, both SIVmac239 and SIVmac316 stim-
ulated early phosphorylation/activation of MAP kinases
independently of their cellular tropism and replication.
RESULTS
Generation of CD41 Jurkat T cells expressing
constitutively CCR5 receptor
To study early signaling events resulting from binding
of SIV to susceptible cells, we first established Jurkat
cells expressing constitutively the CCR5 receptor, which
supports entry of macrophage-tropic HIV-1 (R5 viruses)
as well as macrophage- and T cell-tropic SIV. Jurkat E6–1
cells were transfected with bicistronic vector pIRES1neo
with cloned human CCR5 cDNA as described under
Materials and Methods. A pool of clones of transfected
Jurkat cells, referred here as JCCR5 cells, was used in
further experiments.
By RT-PCR analysis, we have shown that both Jurkat
and JCCR5 cells expressed similar levels of CXCR4
mRNA (Fig. 1A). However, in contrast to parental Jurkat
cells, JCCR5 cells expressed significant levels of CCR5
mRNA (Fig. 1A). In addition, introduction of CCR5 gene
into Jurkat cells did not affect expression of CD4 gene,
and both Jurkat and JCCR5 cells showed similar levels of
CD4 mRNA and CD4 protein (Figs. 1A and 1B). PM1 T
cells that express CD4 and chemokine receptors CXCR4
and CCR5 (Lusso et al., 1995) served as a positive con-
trol.
JCCR5 cells express CCR5 and CXCR4 receptors
functional in cellular signaling
To determine whether the CCR5 receptor expressed in
JCCR5 cells is functional in cellular signaling, we took
advantage of our recent observation that CXCR4 receptor
activates the MEK/ERK pathway when stimulated with a
specific ligand SDF-1a (Popik and Pitha, 1998). There-
fore, to investigate whether CCR5 receptor is able to
signal, JCCR5 cells were stimulated with human macro-
FIG. 1. Expression of CXCR4, CCR5, and CD4 receptors in CD4-
positive Jurkat and JCCR5 T cells. (A) RT-PCR analysis of chemokine
and CD4 mRNA expression in the cells was performed as described
under Materials and Methods. PCR products were resolved by elec-
trophoresis in 2% agarose gel and stained with ethidium bromide. PMI
cells expressing CD4, CXCR4, and CCR5 served as positive control.
GAPDH mRNA served as internal control. (B) Western blot analysis of
CD4 protein expression in Jurkat, JCCR5, and PMI cells. Proteins (50
mg/lane) were resolved by SDS–PAGE (10% gel), transferred to a nitro-
cellulose membrane, and probed with anti-CD4 monoclonal antibody
Q4120. CD4 protein of ;59 kDa is shown.
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phage inflammatory protein-1b (MIP-1b), a specific li-
gand for CCR5 receptor, and activation of cellular mito-
gen-activated protein (MAP) kinase pathways was eval-
uated by Western blot analysis. As shown in Fig. 2, a
5-min exposure to MIP-1b resulted in phosphorylation
and activation of MEK and ERK1/2 as well as p38 MAPK.
Similar to MIP-1b, treatment of JCCR5 cells with SDF-1a
also resulted in rapid phosphorylation and activation of
MEK/ERK1/2 and p38 MAPK pathways. We were unable,
however, to detect any significant stimulation of JNK
phosphorylation. These results indicate that both CXCR4
and CCR5 receptors expressed by JCCR5 cells are func-
tional and able to activate MAP kinase pathways when
stimulated with specific chemokines.
JCCR5 cells are susceptible to infection by
macrophage-tropic HIV-1 and SIV
Because chemokine receptor signaling is dispensable
for HIV entry (Gosling et al., 1997), we investigated fur-
ther whether the expressed CCR5 receptor supports pro-
ductive infection of JCCR5 cells with macrophage-tropic
viruses. Parental Jurkat cells support infection with T
cell-tropic NL4–3 but are resistant to infection with mac-
rophage-tropic Ba-L virus (not shown). In contrast, both
NL4–3 and Ba-L replicated well, although with different
kinetics, in JCCR5 cells as determined by the reverse
transcriptase activity assay (Fig. 3A). In contrast to SIV-
mac316 that replicated in JCCR5 cells with kinetics sim-
ilar to that of Ba-L, replication of SIVmac239 in the cells
was significantly restricted (Fig. 3B). We have shown,
however, the presence of newly synthesized SIV DNA in
JCCR5 cells by PCR analysis using SIV R/U5 primers
(Mori et al., 1993) (Fig. 3C). Therefore, restricted replica-
tion of SIVmac239 in JCCR5 cells was not due to blocked
entry of the virus. Together, our results show that CCR5
receptor expressed in JCCR5 cells function both as an
entry cofactor and signaling molecule.
Binding of SIV enhances MEK/ERK, p38 MAPK, and
JNK phosphorylation in Jurkat cells expressing CCR5
receptor
We have shown recently that both CD4 and CXCR4
receptors were able to stimulate independently phos-
FIG. 3. JCCR5 cells are susceptible to infection by T cell and mac-
rophage-tropic HIV-1 and SIV. The cells were infected (A) with T-tropic
NL4–3 or macrophage-tropic Ba-L or (B) T-tropic SIVmac239 or mac-
rophage-tropic SIVmac316 (105 RT cpm/106 cells). Media from infected
cells were collected every 2 or 3 days and analyzed for the presence of
HIV-1 virions by the RT activity assay. (C) PCR analysis of newly
synthesized SIV DNA in JCCR5 cells. DNA was prepared from Jurkat
and JCCR5 cells infected with SIVmac239 using QIAamp Blood Kit
(Qiagen). DNAs corresponding to SIV R/U5 and b-globin were amplified
by PCR using primers and conditions as described previously (Mori et
al., 1993). PCR products were resolved on 2% agarose gel and stained
with ethidium bromide.
FIG. 2. JCCR5 cells express CCR5 and CXCR4 receptors functional in
cellular signaling. JCCR5 cells were incubated on ice for 30 min with
MIP-1b (500 ng/ml) or SDF-1a (2 mg/ml) or were left untreated (control)
and then incubated at 37°C for 5 min before lysis. Proteins (50 mg/lane)
were resolved by SDS–PAGE, transferred to a nitrocellulose membrane,
and probed with antibodies specific for phosphorylated forms of
MEK1/2 (MEK-P) and ERK1/2 (ERK1/2-P) as well as p38 and JNK (p38-P
and JNK-P, respectively). Positions of phosphorylated MAP kinases are
indicated.
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phorylation and activation of the MEK/ERK pathway in
Jurkat T cells (Popik and Pitha, 1998). In addition, X4
T-tropic NL4–3 virus that is able to infect Jurkat cells and
R5 virus Ba-L unable to enter CCR5-negative Jurkat T
cells, both stimulated phosphorylation of MEK and
ERK1/2 to similar levels. These viruses, however, were
not able to stimulate MAP kinases in the absence of
functional CD4 receptor. These results suggested that
the observed activation of MEK/ERK pathway was CD4
dependent and that CXCR4 receptor was not efficiently
activated in the process of entry of T-tropic virus. In
addition, these results ruled out the possibility that Ba-L
virus may interact with and signal through CXCR4 de-
spite using CCR5 for entry.
To analyze whether viruses that require CCR5 for entry
would activate signaling through this receptor, we stim-
ulated parental Jurkat and JCCR5 cells with T-tropic SIV-
mac239 and macrophage-tropic SIVmac316, both known
to use CCR5 for entry. As shown in Fig. 4A, both viruses
were able to stimulate rapidly phosphorylation of MEK
and ERK1/2 and weakly p38 MAPK and JNK. Similarly, we
observed only a weak activation of p38 MAPK in Jurkat
cells stimulated with NL4–3 and Ba-L but not with mo-
nomeric gp120 or monoclonal anti-CD4 antibody (not
FIG. 4. Binding of T-tropic SIVmac239 and macrophage-tropic SIVmac316 to Jurkat cells expressing CCR5 stimulates phosphorylation of MAP
kinases independently of the viral tropism. (A) Jurkat and JCCR5 cells or (B) Jurkat cells transfected transiently with the CCR5 construct were left
untreated (control) or were incubated on ice for 1 h with sucrose gradient purified SIVmac239 or SIVmac316 virions (5 RT cpm/cell) and then incubated
at 37°C for 5 min before lysis. As a positive control, the cells were incubated at 37°C for 5 min with MIP-1b (500 ng/ml). Proteins (50 mg/lane) were
resolved by SDS–PAGE, transferred to a nitrocellulose membrane, and probed with antibodies specific for phosphorylated forms of MEK1/2 (MEK-P),
ERK1/2 (ERK1/2-P), p38 (p38-P), and JNK (JNK-P) as well as with antibodies specific for total MAP kinases. Positions of phosphorylated and total MAP
kinases are indicated.
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shown). This observation suggest that oligomerization of
CD4 receptors by virus particles may be required for the
observed modest stimulation of p38 MAPK.
In contrast to T cell-tropic NL4–3 that was unable to
efficiently activate CXCR4 in the process of entry, SIV-
mac239 and SIVmac316 significantly upregulated the
phosphorylation of MEK and ERK1/2 in JCCR5 cells
(Fig. 4A). In addition, both SIVmac efficiently increased
phosphorylation of p38 MAPK and JNK in JCCR5 cells
in comparison with Jurkat cells (Fig. 4A). To further
confirm that the observed effects are related to the
expression of CCR5 receptor, we performed a similar
analysis using Jurkat cells transfected transiently with
CCR5 construct (Fig. 4B). We have found that both
SIVmac significantly enhanced phosphorylation of
MEK, ERK, p38, and JNK. Interestingly, stimulation of
MAP kinase pathways by SIVmac was independent of
differential utilization of the CCR5 receptor by SIV-
mac239 and SIVmac316 in the process of entry and
virus replication.
DISCUSSION
In this report, we show activation of MAPK signaling
induced by binding of macrophage-tropic SIVmac316 and
T-tropic SIVmac239 in Jurkat cells expressing CCR5 re-
ceptor. Our results demonstrate that although activation
of MEK/ERK pathway requires only interaction of HIV-1 or
SIV with CD4 receptor, SIVmac that is using CCR5 re-
ceptor for entry significantly increased activation of MEK/
ERK as well as p38 and JNK in cells expressing CCR5. In
contrast, T-tropic NL4–3 virus was unable to use effi-
ciently signaling potential of CXCR4 receptor and stimu-
lated MEK/ERK pathway exclusively through the CD4
receptor (Popik and Pitha, 1998). Although chemokine
receptor signaling seems to be dispensable for virus
entry (Edinger et al., 1997b; Gosling et al., 1997), it is not
known whether signaling plays a role in postentry stages
of virus replication in primary cells and AIDS pathogen-
esis. However, there is evidence to suggest that HIV-1
coreceptors participate in postentry stages in the virus
replication cycle (Chackerian et al., 1997). In addition,
chemokine receptor signaling was suggested as one of
the mechanisms by which certain viruses may affect
intracellular environment in macrophages to allow for
completion of reverse transcription and efficient replica-
tion (Schmidtmayerova et al., 1998; Smyth et al., 1998).
However, inability of SIVmac239 to replicate in JCCR5
cells despite its entry and activation of MAPK pathways
may suggest that there are other factors in addition to
signaling that may restrict replication of SIVmac239 in
JCCR5 cells.
It is unlikely that the observed stimulation of p38 and
JNK by SIVmac in JCCR5 cells results from higher ex-
pression and consequently enhanced signaling through
CD4 receptor in JCCR5 cells because no significant in-
crease in the levels of CD4 expression measured at RNA
and protein levels was observed in JCCR5 cells. In ad-
dition, transient transfection experiments show that an
increased activation of MAPK by SIVmac correlates with
the expression of CCR5. The other possibility is that
expression of CCR5 may positively affect signaling po-
tential of CD4 receptor. Experiments are in progress to
address this problem. Based on our current observa-
tions, we conclude that the observed upregulation of
MAP kinase pathways in JCCR5 cells results from the
stimulation of both CD4 and CCR5 receptor signaling on
binding of SIVmac.
Our observation that SIVmac239 and SIVmac316,
which use different CCR5 regions for entry, stimulate
MAP kinases to similar levels was unexpected in light of
recent studies showing that entry of T cell-tropic SIV-
mac239 requires the second extracellular domain of
CCR5, whereas macrophage-tropic SIVmac316 is using
the N-terminal domain of CCR5 receptor (Edinger et al.,
1997b). However, it is possible that interactions between
SIV and CCR5 may be more complex, and in addition to
different binding domains required for entry, these vi-
ruses may interact with common CCR5 structural do-
mains involved in the process of signaling as proposed
recently for R5 HIV-1 (Alkhatib et al., 1997).
The significance of the early p38 and JNK activation in
the pathogenesis of SIV is currently unknown; however,
in the light of recent findings, the role of p38 and JNK in
apoptosis and/or cell survival cannot be excluded. We
and others have shown that Fas ligand gene is ex-
pressed early in Jurkat cells through a CD4-dependent
mechanism (Algeciras et al., 1998; Faris et al., 1998;
Popik and Pitha, 1998). Therefore, it is possible that early
activation of p38 and JNK may regulate cell survival in
response to SIV. A similar cell survival mechanism has
been recently proposed in response to tumor necrosis
factor-a (Roulston et al., 1998). Signaling to JNK and p38
kinase is initiated within 5 min of exposure to SIV, before
Fas ligand induction, and this could mediate survival
signals during exposure to SIV. However, we cannot rule
out the possibility that JNK and p38 signaling may actu-
ally stimulate apoptosis possibly through activation of
the Fas ligand gene expression. We are currently testing
these possibilities.
In summary, we have found that in contrast to
NL4–3, which uses CXCR4 for entry, SIVmac239 and
SIVmac316 efficiently stimulated p38 and JNK activa-
tion, possibly through binding to CD4 and CCR5 re-
ceptors. Interestingly, MAP kinase activation was in-
dependent of SIV tropism and replication of the vi-
ruses and was significantly increased in cells
expressing CCR5. The role of MAPK pathways in the
pathogenesis of CCR5- versus CXCR4-using viruses
awaits further investigation.
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MATERIALS AND METHODS
Reagents and materials
Human chemokine MIP-1b was obtained from R&D
Systems (Minneapolis, MN). SDF-1a was a generous gift
from Dr. J. Hesselgesser (Berlex Biosciences, Richmond,
CA). Phosphospecific antibodies detecting phosphory-
lated and activated forms of MEK1/2 (Ser217/221),
ERK1/2 (Thr202/Tyr204), p38MAPK (Thr180/Tyr182), and
JNK (Thr183/Tyr185) as well as antibodies detecting total
levels of these kinases, were purchased from New En-
gland Biolabs. Monoclonal antibodies, anti-Flag M2, and
anti-CD4 Q4120 were from Sigma. Bicistronic vector
pIRES1neo was purchased from Clontech.
Construction of Jurkat cells expressing constitutively
CCR5 receptor
Human CCR5 cDNA, tagged at the amino acid termi-
nus with Flag epitope (provided by Dr. I. F. Charo, Glad-
stone Institute, UCSF), was cut out from the expression
vector pcDNA3 with HindIII and XbaI, blunt ended with
Klenow fragment of DNA polymerase I, and subcloned
into bicistronic pIRES1neo vector linerized with EcoRV.
The DNA was transfected using Superfect reagent (Qia-
gen) into Jurkat T cells, clone E6–1 (American Type Cul-
ture Collection TIB-152). The cells were then selected in
the presence of G418 (1 mg/ml). A pool of cells surviving
G418 selection (JCCR5neo cells) was used in experi-
ments. The cell surface expression of CCR5 was deter-
mined in an ELISA using anti-Flag M2 monoclonal anti-
body, by stimulation of the signal transduction pathway
with a specific CCR5 receptor ligand MIP-1b, and by
infectibility of the transfected cells with macrophage-
tropic HIV-1 Ba-L as well as SIVmac239 and SIVmac316,
which use CCR5 receptor for entry. In addition, the pres-
ence of CCR5 mRNA in transfected cells was detected by
RT-PCR analysis.
Transient transfection of Jurkat T cells
The cells were harvested by centrifugation and
washed once in serum-free RPMI 1640 medium. Cells
(2 3 107) were resuspended in 500 ml of RPMI medium
containing 20 mg of plasmid DNA (CCR5 in pIRES1neo)
and electroporated at 260 V and 960 mF using a Gene
Pulser II (BioRad laboratories). Electroporated cells were
cultured overnight in RPMI medium supplemented with
10% FCS, washed, and starved for an additional 24 h in
RPMI medium supplemented with 0.1% FCS before stim-
ulation.
Cell cultures
Jurkat T cells, clone E6–1, and PM1 T cells were
maintained in RPMI 1640 medium supplemented with
10% FCS (Gemini Bio-Products, CA), 2 mM L-glutamine,
and gentamicin (50 mg/ml). JCCR5neo cells were propa-
gated in the RPMI medium additionally supplemented
with G418 (1 mg/ml). Before use in signal transduction
experiments, the cells were starved for 24 h in RPMI
medium containing 0.1% FCS in the absence of selection
antibiotic G418.
Virus stock preparation and virus titer
Viral stock of the T cell-tropic NL4–3 clone of HIV-1
was prepared by transfecting Jurkat cells with plasmid
DNA as described (Popik and Pitha, 1996). Viral stocks of
T-tropic SIVmac239 and macrophage-tropic SIVmac316
(obtained from Dr. J. E. Clements, JHU, Baltimore, MD)
were prepared by infecting CEMx174 cells. HIV-1 Ba-L
(obtained from Dr. S. Gartner, JHU, Baltimore, MD) was
propagated in PM1 cells. Culture supernatants contain-
ing viruses were clarified by low-speed centrifugation
and filtration through a 0.45-mm filter and kept frozen at
280°C. Before use, virus was concentrated and purified
by ultracentrifugation through a cushion of sucrose
buffer as described previously (Popik and Pitha, 1996).
The virus titer was monitored by the RT activity assay as
described previously (Su et al., 1995).
Cell treatment and Western blot analysis
Cell aliquots were exposed to chemokines SDF-1a (2
mg/ml) or MIP-1b (500 ng/ml) on ice for 30 min or were
preincubated on ice for 60 min with purified viruses (5 RT
units/cell). The cells were then transferred to 37°C and
incubated for the indicated times followed by washing
with ice-cold PBS and lysis in 1% Triton X-100 buffer
supplemented with protease and phosphatase inhibitors
as described (Popik and Pitha, 1998). After 30 min on ice,
the lysates were clarified by centrifugation and protein
concentration was determined with the Pierce BCA pro-
tein assay reagent. Proteins (50 mg) were resolved by
SDS–PAGE (10% acrylamide), transferred to nitrocellu-
lose membranes, and probed with specific antibodies
(diluted 1:1000) followed by incubation with secondary
horseradish peroxidase-conjugated antibody (1:100,000).
Bound antibodies were detected with the SuperSignal
ULTRA chemiluminescent substrate (Pierce).
RT-PCR analysis of CD4 and chemokine receptor
mRNA expression
Total RNA was isolated from cells with RNeasy RNA
purification system (Qiagen), and 1 mg of DNase-treated
RNA was used for cDNA synthesis using Superscript II
RNase H2 reverse transcriptase and oligo (dT)12–18 prim-
ers (GIBCO-BRL); one tenth of this reaction was used as
a template for PCR amplification with Taq polymerase
(Supermix, BRL). Primers for CXCR4, CCR5, CD4 (Yi et al.,
1998), and GAPDH (McKnight et al., 1997) were de-
scribed. Amplifications were performed for 30 cycles
(94°C for 45 s, 50°C for 1 min, and 72°C for 1.5 min), and
PCR products were resolved by electrophoresis in 2%
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agarose gels and visualized by ethidium bromide stain-
ing.
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